STRASBOURG, France--Paul Berg, director of the Beckman Center for Molecular and Genetic Research at Stanford University School of Medicine, and G. Steven Burrill, CEO of Burrill & Company, a private merchant bank specializing in life sciences companies, have joined the board of directors at integrated biotech firm Transgene here.

Winner of the Nobel Prize for chemistry in 1980 for his studies of the biochemistry of nucleic acids with a specific emphasis on recombinant DNA, Berg will also participate in meetings of Transgene's scientific board.